about
The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and AdipogenesisGene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING StudiesNocturnin: a circadian target of Pparg-induced adipogenesis.Associations between serum leptin level and bone turnover in kidney transplant recipients.Vertebral bone marrow fat, bone mineral density and diabetes: The Osteoporotic Fractures in Men (MrOS) study.RAGE supports parathyroid hormone-induced gains in femoral trabecular boneBone marrow fat accumulation accelerated by high fat diet is suppressed by exercise.An adenosine receptor-Krüppel-like factor 4 protein axis inhibits adipogenesis.Caloric restriction leads to high marrow adiposity and low bone mass in growing miceSerum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndromeMinireview: A skeleton in serotonin's closet?Emerging therapeutic opportunities for skeletal restoration.Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.Skeletal aging and the adipocyte program: New insights from an "old" molecule.Hormone-sensitive lipase-knockout mice maintain high bone density during aging.Why does starvation make bones fat?Marrow fat metabolism is linked to the systemic energy metabolismThe role of osteocalcin in human glucose metabolism: marker or mediator?A high-fat diet induces bone loss in mice lacking the Alox5 geneNovel insights into the relationship between diabetes and osteoporosisOsteocalcin and the Regulation of Glucose MetabolismNew mutations at the imprinted Gnas cluster show gene dosage effects of Gsα in postnatal growth and implicate XLαs in bone and fat metabolism but not in suckling.Ethnic and sex differences in bone marrow adipose tissue and bone mineral density relationshipGenetic evidence that thyroid hormone is indispensable for prepubertal insulin-like growth factor-I expression and bone acquisition in mice.Circulating osteocalcin level is not associated with incident type 2 diabetes in middle-aged male subjects: mean 8.4-year retrospective follow-up studyThe effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes.Increased Gs Signaling in Osteoblasts Reduces Bone Marrow and Whole-Body Adiposity in Male Mice.Mesenchymal stem cells, aging and regenerative medicine.Efficient isolation of bone marrow adipocyte progenitors by silica microbeads incubation.Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ.Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted miceIntercellular cross-talk among bone cells: new factors and pathways.Obesity and fracture in men and women: an epidemiologic perspective.Diabetes mellitus and osteoporosis.Underweight, overweight, and pediatric bone fragility: impact and management.Association between serum osteocalcin and body mass index: a systematic review and meta-analysis.Biophysical Stimulation for Bone Regeneration.Peroxisome proliferator-activated receptor gamma/signal transducers and activators of transcription 5A pathway plays a key factor in adipogenesis of human bone marrow-derived stromal cells and 3T3-L1 preadipocytes.Formononetin, an isoflavone, activates AMP-activated protein kinase/β-catenin signalling to inhibit adipogenesis and rescues C57BL/6 mice from high-fat diet-induced obesity and bone loss.
P2860
Q26738893-296E434C-C33E-4CF4-9A51-2610D952BE6EQ28397345-18457198-750B-4C99-AFD7-E0A0FEC52F98Q30423863-C22D9B17-2ADC-499C-BD20-E068A5AF6638Q30429441-DFB26A33-76E2-4844-B15D-BB821E797449Q31160528-611B134C-BEB0-4094-9474-8FC86A97FDEFQ33520403-C708D9A2-E2FB-4FEC-9692-6DCD26D631EBQ33700277-9528DD61-989B-40F2-82B1-D9E8EE744FC8Q33947244-62617D31-9B92-472B-BA72-7A76E408C979Q34103989-D951BD11-6B17-4C99-ADA5-1E487BDA8460Q34129927-99E7B52C-EAAE-4B07-B785-3528D06465D9Q34132327-ED63DC6D-35F0-473A-AFD3-227BA4554208Q34161867-536ADB29-6AEA-4D1E-8639-54012983FE8EQ34388316-0110C313-AAA6-4A9C-9293-7427CE94C0EFQ34619735-FB43EA31-9C61-4ED3-BFD3-2FFEDB12F74AQ35105396-A0CA8E40-78FF-4767-9950-3260E9EC6FAFQ35202573-B32F7C72-3F73-4F62-A449-F9E140C501F6Q35403424-EC9533F3-36B0-4A01-9F58-44E30156F39BQ35636353-DBB5EA0C-7A0B-4FEC-B418-9A2DFC310DE4Q35646073-824CCBB9-B2D4-42E7-AFCA-13155D548D62Q35674683-8EC247B3-2524-4CFA-877F-F6384E0A0AF6Q35765440-44904B84-F411-4AE3-A6EB-DADCF80C9958Q35807252-6CFBCA4D-58E4-4370-89EB-8E8C73BAC1BFQ36044509-AACD90FC-0462-4E98-98FE-EEB8C7398F42Q36103498-8BE3DC43-7235-46B6-B22D-BD6445D459BCQ36181331-3E2F462D-E479-4433-A652-0C395AC5C40EQ36536852-8372D6B7-BC92-4F15-B942-97E89CC24DE4Q36753806-D23CACD8-2EC7-4CCF-8B9B-852B4822E4D1Q36883559-573FF124-E7FE-46E4-B028-E3945FB221A9Q37139483-903B2E25-5756-49BA-84EB-0048490BB35AQ37266142-ACFCB649-2225-4161-A449-3EE36C87B693Q37319591-AD6531F8-6C75-4BC5-9703-A1B6F878C183Q37518446-50A539C1-CD00-464B-91F7-C925FC2DC7F1Q37994636-0851E816-AFE0-49E3-9ABE-BAF68A575F0CQ38076660-16A56B9B-BE30-4988-9DB2-D4979889AA7EQ38087556-020D78E4-E068-4C12-B42F-C2E579B7B572Q38225482-8EE6AFFD-00EC-4166-98F1-A3DAD2E5ECD0Q38617812-772BF840-004F-43BC-8E92-36F1DB005F3EQ39281698-2F30F5C8-84A4-4BC4-9F94-733AC5F7ED1CQ40848790-7005C9F3-082B-4628-A835-44A4AAD77A53Q42801551-AA0B897E-59FA-4A18-B37A-21DD38459578
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Fat targets for skeletal health
@en
type
label
Fat targets for skeletal health
@en
prefLabel
Fat targets for skeletal health
@en
P2860
P356
P1476
Fat targets for skeletal health
@en
P2093
Clifford J Rosen
Masanobu Kawai
P2860
P2888
P304
P356
10.1038/NRRHEUM.2009.102
P407
P577
2009-05-26T00:00:00Z